CCL2 and cancer: The expression of STAT3 in cancer-associated fibroblasts promotes the recruitment of myeloid-derived suppressor cells (MDSCs) in to the tumor by the production of C-C motif chemokine ligand 2 (CCL2) to create an immunosuppressive TME.